A Phase 2 Evaluation of Irofulven as Second-Line Treatment of Recurrent or Persistent Intermediately Platinum-Sensitive Ovarian or Primary Peritoneal Cancer: A Gynecologic Oncology Group Trial

AuthID
 P-00V-T60
9
Author(s)
Schilder R.J.
·
Blessing J.A.
·
Shahin M.S.
·
Tewari K.S.
·
Muller C.Y.
·
Warshal D.P.
·
McMeekin S.
·
Document Type
Article
Year published
2010
Published
in International Journal of Gynecological Cancer, ISSN: 1048-891X
Volume: 20, Issue: 7, Pages: 1137-1141 (4)
Indexing
Scopus®
Crossref®13
Pubmed®
Google Scholar®
Publication Identifiers
Pubmed: 21495215
Scopus: 2-s2.0-79960671502
Source Identifiers
ISSN: 1048-891X
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

footer slogan

Useful Links

Get Help

© 2025 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service